IN 2015, CLOTASSIST BEGAN AS A COLLABORATIVE PILOT STUDY TO PROVIDE AN ALTERNATE CARE PATHWAY TO THE EMERGENCY DEPARTMENT FOR PATIENTS NEWLY DIAGNOSED WITH CANCER ASSOCIATED THROMBOSIS. THE DATA WAS PUBLISHED IN THE JOURNAL OF ONCOLOGY PHARMACY PRACTICE. CLICK THE LINK BELOW TO VIEW:
ClotAssist: A program to treat cancer associated thrombosis in an outpatient pharmacy setting
Starting Treatment of a Blood Clot in Patients with Cancer
Patients who develop clots and are clinically stable may not be able to receive treatment at the cancer centre because they cannot reach the cancer centre before it closes, or there is no space at the cancer centre to complete the required teaching. As a result, the patient is referred to the emergency department for treatment. For many patients, their experience in the emergency department is challenging, often characterized by long waits and poor followup. For some patients, the diagnosis of a clot can be more traumatic to a patient than the cancer itself.
To address this care gap, a project was developed in partnership with Shoppers Drug Mart North Hill Centre. These pharmacists have received specialized training, and on receipt of a requisition form identifying the diagnosis, the pharmacist will initiate therapy, train the patient to self-inject low molecular weight heparin using a bruiseless injection technique, follow up with the patient the next day by phone, and communicate a summary back to the oncologist and the patient's family physician. Data collected from patients utilizing the pharmacy gathered by anonymous patient surveys point to a much more positive experience. This also represents a significant savings to the health care system.
Click here to learn exactly what the pharmacist will do and how health care providers can refer their patients.
Preventing Blood Clots in Pregnant Patients with High Risk
The risk of a blood clot in healthy pregnant individual is 0.5 in 1000 throughout the duration of their pregnancy. However, some patients are predisposed to blood clots and their risk of a blood clot can increase by 10 fold or more. Clot prevention using low molecular weight heparin (LWMH) is the recommended course of action for many of these patients. Physicians can refer their patient to the the Shoppers Drug Mart in North Hill Centre, where the pharmacists will utilize their specialized training to initiate therapy with LWMH, train the patient to inject using a bruiseless injection technique, follow up with the patient the next day by phone, and communicate a summary back to the family physician.
Click here to learn exactly what the pharmacist will do and how health care providers can refer patients to this service.
We ask every patient to complete a short, anonymous, survey with 4 multiple choice questions and an optional open ended question. Here are what patients are saying: